[1]
“Centrality Measures in QSPR Modelling of Antiviral Compounds for COVID-19”, IJLTEMAS, vol. 14, no. 12, pp. 1135–1158, Jan. 2026, doi: 10.51583/IJLTEMAS.2025.1412000101.